Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: A meta-analysis

Gastrointestinal Endoscopy

Volumn 76, Issue 6, 2012, Pages 1252-1259

  Ding, Xiwei ^a,b   Chen, Min ^a   Huang, Shuling ^a   Zhang, Song ^a   Zou, Xiaoping ^a  

^a NANJING UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; VALDECOXIB;

ARTICLE; BILE DUCT STONE; BILIARY TRACT DISEASE; BLEEDING; CHOLANGITIS; CHOLECYSTITIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; META ANALYSIS; ODDI SPHINCTER; PANCREATITIS; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 84869187208     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2012.08.021     Document Type: Article

References (37)

1. M.L. Freeman, N.M. Guda Prevention of post-ERCP pancreatitis: a comprehensive review Gastrointest Endosc 59 2004 845 864
2. N.M. Davies, K.E. Anderson Clinical pharmacokinetics of diclofenac Therapeutic insights and pitfalls Clin Pharmacokinet 33 1997 184 213
3. V. Gross, H.G. Leser, A. Heinisch Inflammatory mediators and cytokines-new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 40 1993 522 530
4. A. Makela, T. Kuusi, T. Schroder Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro Scand J Clin Lab Invest 57 1997 401 407
5. P.M. Wildenhain, M.F. Melhem, W.I. Birsic Acute hemorrhagic pancreatitis in mice: improved survival after indomethacin administration Digestion 44 1989 41 51
6. B.J. Elmunzer, A.K. Waljee, G.H. Elta A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis Gut 57 2008 1262 1267
7. M.H. Zheng, H.H. Xia, Y.P. Chen Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis Gut 57 2008 1632 1633
8. Y.K. Cheon, K.B. Cho, J.L. Watkins Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial Gastrointest Endosc 66 2007 1126 1132
9. A. Senol, U. Saritas, H. Demirkan Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis World J Gastroenterol 15 2009 3999 4004
10. F. Elmi, F. Rossi, J.K. Lim A prospective, multicenter, randomized, double blinded controlled study to determine whether a single dose of intraduodenal indomethacin can decrease the incidence and severity of post-ERCP pancreatitis [abstract] Gastrointest Endosc 71 2010 AB232
11. V. Bhatia, V. Ahuja, S.K. Acharya A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis J Clin Gastroenterol 45 2011 170 176
12. B.J. Elmunzer, J.M. Scheiman, G.A. Lehman A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis N Engl J Med 366 2012 1414 1422
13. T. Otsuka, S. Kawazoe, S. Nakashita Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial J Gastroenterol 45 2012 012 017
14. A.R. Jadad, R.A. Moore, D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
15. J.P. Higgins, S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
16. J.P. Higgins, S.G. Thompson, J.J. Deeks Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
17. J. Robins, N. Breslow, S. Greenland Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models Biometrics 42 1986 311 323
18. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
19. C.B. Begg, M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
20. M. Egger, G. Davey Smith, M. Schneider Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
21. A. Montaño Loza, J.E. Garcia Correa, A. Gonzàlez Ojeda Prevention of hyperamilasemia and pancreatitis after endoscopic retrograde cholangiopancreatography with rectal administration of indomethacin [in Spanish] Rev Gastroenterol Mex 71 2006 262 268
22. A. Montaño Loza, X. Rodríguez Lomeli, J.E. Garcia Correa Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes [in Spanish] Rev Esp Enferm Dig 99 2007 330 336
23. V. Bhatia, P. Garg, V. Ahuja Valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis: a randomized controlled trial [abstract] J Gastroenterol Hepatol 24 2009 A84
24. P. Katsinelos, K. Fasoulas, G. Paroutoglou Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial Endoscopy 44 2012 53 59
25. B. Murray, R. Carter, C. Imrie Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography Gastroenterology 124 2003 1786 1791
26. R. Sotoudehmanesh, M. Khatibian, S. Kolahdoozan Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP Am J Gastroenterol 102 2007 978 983
27. M. Khoshbaten, H. Khorram, L. Madad Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis J Gastroenterol Hepatol 23 2008 e11 e16
28. P.B. Cotton, G. Lehman, J. Vennes Endoscopic sphincterotomy complications and their management: an attempt at consensus Gastrointest Endosc 37 1991 383 393
29. E.R. Bradley A clinically based classification system for acute pancreatitis Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992 Arch Surg 128 1993 586 590
30. J.H. Ranson, K.M. Rifkind, D.F. Roses Prognostic signs and the role of operative management in acute pancreatitis Surg Gynecol Obstet 139 1974 69 81
31. D.B. Nelson, M.L. Freeman Major hemorrhage from endoscopic sphincterotomy: risk factor analysis J Clin Gastroenterol 19 1994 283 287
32. M.L. Freeman, D.B. Nelson, S. Sherman Complications of endoscopic biliary sphincterotomy N Engl J Med 335 1996 909 918
33. T. Mazaki, H. Masuda, T. Takayama Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis Endoscopy 42 2010 842 853
34. A. Choudhary, M.L. Bechtold, M. Arif Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review Gastrointest Endosc 73 2011 275 282
35. J.M. Dumonceau, J. Rigaux, M. Kahaleh Prophylaxis of post-ERCP pancreatitis: a practice survey Gastrointest Endosc 71 2010 934 939 931-9
36. A. Das, P. Singh, M.J. Sivak Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis Gastrointest Endosc 65 2007 960 968
37. D. Moher, B. Pham, A. Jones Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352 1998 609 613